End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
1.09
CNY
|
+2.83%
|
|
+6.86%
|
-25.85%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,292
|
7,927
|
4,518
|
14,217
|
7,509
|
6,201
|
Enterprise Value (EV)
1 |
7,376
|
7,573
|
3,651
|
13,327
|
7,233
|
5,861
|
P/E ratio
|
-0.77
x
|
-1.23
x
|
138
x
|
348
x
|
742
x
|
-46.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.14
x
|
11.1
x
|
31.9
x
|
32.8
x
|
12
x
|
12.4
x
|
EV / Revenue
|
3.65
x
|
10.6
x
|
25.8
x
|
30.7
x
|
11.5
x
|
11.7
x
|
EV / EBITDA
|
-6.18
x
|
-23
x
|
168
x
|
476
x
|
-4,394
x
|
320
x
|
EV / FCF
|
8.95
x
|
-3.63
x
|
6.82
x
|
-2,515
x
|
-33
x
|
-124
x
|
FCF Yield
|
11.2%
|
-27.6%
|
14.7%
|
-0.04%
|
-3.03%
|
-0.81%
|
Price to Book
|
-2.15
x
|
7.2
x
|
4
x
|
12.2
x
|
6.18
x
|
5.74
x
|
Nbr of stocks (in thousands)
|
1,805,043
|
4,261,877
|
4,261,877
|
4,218,688
|
4,218,688
|
4,218,688
|
Reference price
2 |
1.270
|
1.860
|
1.060
|
3.370
|
1.780
|
1.470
|
Announcement Date
|
4/29/19
|
4/28/20
|
3/25/21
|
3/31/22
|
4/13/23
|
4/11/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,020
|
714.6
|
141.6
|
433.5
|
628.3
|
499.7
|
EBITDA
1 |
-1,194
|
-329.4
|
21.68
|
27.97
|
-1.646
|
18.3
|
EBIT
1 |
-1,434
|
-538.5
|
21.59
|
24.96
|
-15.71
|
-20.73
|
Operating Margin
|
-70.98%
|
-75.35%
|
15.25%
|
5.76%
|
-2.5%
|
-4.15%
|
Earnings before Tax (EBT)
1 |
-2,957
|
-2,732
|
33.31
|
45.65
|
12.07
|
-133.6
|
Net income
1 |
-2,983
|
-2,732
|
33.02
|
40.87
|
10.28
|
-135.3
|
Net margin
|
-147.7%
|
-382.32%
|
23.32%
|
9.43%
|
1.64%
|
-27.07%
|
EPS
2 |
-1.653
|
-1.514
|
0.007700
|
0.009689
|
0.002400
|
-0.0317
|
Free Cash Flow
1 |
824.2
|
-2,087
|
535.4
|
-5.3
|
-219.4
|
-47.39
|
FCF margin
|
40.81%
|
-292.12%
|
378.2%
|
-1.22%
|
-34.92%
|
-9.48%
|
FCF Conversion (EBITDA)
|
-
|
-
|
2,469.34%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
1,621.7%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/29/19
|
4/28/20
|
3/25/21
|
3/31/22
|
4/13/23
|
4/11/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
5,084
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
354
|
867
|
890
|
277
|
340
|
Leverage (Debt/EBITDA)
|
-4.257
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
824
|
-2,087
|
535
|
-5.3
|
-219
|
-47.4
|
ROE (net income / shareholders' equity)
|
-709%
|
-17,489%
|
2.96%
|
3.59%
|
0.52%
|
-11.9%
|
ROA (Net income/ Total Assets)
|
-8.73%
|
-6.98%
|
1.08%
|
1.21%
|
-0.65%
|
-0.83%
|
Assets
1 |
34,177
|
39,131
|
3,063
|
3,383
|
-1,577
|
16,326
|
Book Value Per Share
2 |
-0.5900
|
0.2600
|
0.2600
|
0.2800
|
0.2900
|
0.2600
|
Cash Flow per Share
2 |
0.1600
|
0.0900
|
0.2100
|
0.2100
|
0.0900
|
0.0700
|
Capex
1 |
9.45
|
14.6
|
14.5
|
42.2
|
90.7
|
72.7
|
Capex / Sales
|
0.47%
|
2.04%
|
10.24%
|
9.74%
|
14.44%
|
14.54%
|
Announcement Date
|
4/29/19
|
4/28/20
|
3/25/21
|
3/31/22
|
4/13/23
|
4/11/24
|
|
1st Jan change
|
Capi.
|
---|
| -25.85% | 617M | | +11.76% | 63.22B | | -3.51% | 46.34B | | +13.09% | 39.97B | | +17.83% | 25.46B | | +8.37% | 18.68B | | +1.44% | 17.24B | | -20.33% | 15.81B | | +0.36% | 14.9B | | -12.98% | 13.74B |
Other Specialty Chemicals
|